In 2016, Tracer Yong obtained his MBBS at Peking University (北京大學). He then moved to London where he began his research career and earned his MSc in Infection and Immunity at University College London (2018). After that, he lead a project at Academia Sinica in Taiwan developing a therapeutic cancer vaccine, during which he developed great interest towards tumour-host interaction and B cell immunology.
Tracer Yong is now undertaking his PhD training in Lisa Westerberg's group at Karolinska Institute to investigate B cell lymphoma.
Tracer Yong is a certified PADI open water diver and a former violinist at Peking University Symphony Orchestra.
Oliveira, M.M.S., D’Aulerio, R., Yong, T. et al. Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666. Br J Cancer (2023). https://doi.org/10.1038/s41416-022-02135-4
Yong, T.; Chang, K.-K.; Wang, Y.-S.; Ma, C. Active Humoral Response Reverts Tumorigenicity through Disruption of Key Signaling Pathway. Vaccines 2022, 10, 163. https://doi.org/10.3390/vaccines10020163
Mersmann SF, Johns E, Yong T, McEwan WA, James LC, Cohen EAK, Grove J. A novel and robust method for counting components within bio-molecular complexes using fluorescence microscopy and statistical modelling. Sci Rep. 2022 Oct 14;12(1):17286. https://doi.org/10.1038/s41598-022-20506-y
RECOMBINANT POLYPEPTIDES, CONJUGATES COMPRISING THE SAME, AND USES THEREOF. Che Ma, Wen-Hua Lee, Tracer Yong. (2021) https://iptt.sinica.edu.tw/shares/1095
PhD Tumour Immunology - Karolinska Institute, Sweden, Since 2021
MSc Infection and Immunity - University College London, UK, 2018
MBBS - Peking University (北京大學), China, 2016